methyl 4'-(phenethylcarbamoyl)-2,2'-bipyridine-4-carboxylate

ID: ALA5278119

Chembl Id: CHEMBL5278119

Max Phase: Preclinical

Molecular Formula: C21H19N3O3

Molecular Weight: 361.40

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccnc(-c2cc(C(=O)NCCc3ccccc3)ccn2)c1

Standard InChI:  InChI=1S/C21H19N3O3/c1-27-21(26)17-9-12-23-19(14-17)18-13-16(8-11-22-18)20(25)24-10-7-15-5-3-2-4-6-15/h2-6,8-9,11-14H,7,10H2,1H3,(H,24,25)

Standard InChI Key:  LTHOPIBLRVRXLD-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5278119

    ---

Associated Targets(Human)

MM1.S (1111 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5A Tchem Lysine-specific demethylase 5A (893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5B Tchem Lysine-specific demethylase 5B (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDM5C Tchem Lysine-specific demethylase 5C (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.40Molecular Weight (Monoisotopic): 361.1426AlogP: 2.90#Rotatable Bonds: 6
Polar Surface Area: 81.18Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.63CX LogP: 3.05CX LogD: 3.05
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -0.76

References

1. Yang GJ, Wu J, Miao L, Zhu MH, Zhou QJ, Lu XJ, Lu JF, Leung CH, Ma DL, Chen J..  (2021)  Pharmacological inhibition of KDM5A for cancer treatment.,  226  [PMID:34555614] [10.1016/j.ejmech.2021.113855]

Source